About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
This virtual conversation, hosted by the American Committee, features Weizmann’s Dr. Ravid Straussman, the NIH’s Dr. Daniel Douek (Chief of the Human Immunology Section of the Vaccine Research Center), and is moderated by Dr. Alan Leishner, former CEO of the American Association for the Advancement of Science, which publishes the prestigious journal Science.
December 17, 2020
REHOVOT, ISRAEL—December 16, 2020—Cancers like melanoma are hard to treat, not least because they have a varied bag of tricks for defeating or evading treatments. Now, a combined research effort by the Weizmann Institute of Science...
December 16, 2020
Haaretz Magazine profiles the remarkable immunologist Prof. Ido Amit, whose single-cell genomics technique is transforming science and may defeat a range of diseases.
November 21, 2020
October is National Breast Cancer Awareness Month, a time that is typically packed with runs, walks, and other events. While this year is different due to the coronavirus, stepping up to support and advance the science is as important as ever.
Breast cancer research is actively underway at the Weizmann Institute of Science, with researchers applying their formidable skills to improve understanding, diagnosis, and treatment of this still-too-common disease. Working in collaboration with oncologists and other medical professionals around the world, Institute scientists are continually making groundbreaking progress, demonstrating the role that curiosity-driven, interdisciplinary science plays in the battle against breast cancer. Just a few of the innovative projects taking place right now include:
Blood cancers are far too common, comprising almost 10% of new cancer diagnoses each year in the U.S. Almost every 10 minutes, an American succumbs to a blood cancer. Unfortunately, many of these are children.
That's why the Weizmann Institute of Science’s researchers are conducting innovative studies and taking novel approaches to blood cancers. September is Blood Cancer Awareness Month, and we’d like to share with you some of Weizmann’s current investigations.
September 2020
The Jerusalem Post reports on a technology, developed by Prof. Ido Amit and team, that reveals the inner functions of cells. This could lead to new cancer immunotherapies.
August 14, 2020
REHOVOT, ISRAEL—July 16, 2020—Choosing the right drug for each cancer patient is key to successful treatment, but physicians currently have few reliable pointers to guide them in designing treatment protocols. Researchers at the Weizmann Institute of Science and the Broad Institute of MIT and Harvard have now developed a new method...
July 16, 2020
REHOVOT, ISRAEL—June 2, 2020—Cancer cells are comfy havens for bacteria. That conclusion arises from a rigorous study of over 1,000 tumor samples of different human cancers.
June 02, 2020
Covering the recent breakthrough by Dr. Ravid Straussman, New Scientist says that the “first comprehensive survey of the microorganisms that live inside tumours has found that bacteria reside in those from many different cancer types.”
May 28, 2020